HNRG vs. CERE, CNX, HCC, ARCH, METC, AREC, CEIX, BORR, PUMP, and PDS
Should you be buying Hallador Energy stock or one of its competitors? The main competitors of Hallador Energy include Cerevel Therapeutics (CERE), CNX Resources (CNX), Warrior Met Coal (HCC), Arch Resources (ARCH), Ramaco Resources (METC), American Resources (AREC), CONSOL Energy (CEIX), Borr Drilling (BORR), ProPetro (PUMP), and Precision Drilling (PDS).
Cerevel Therapeutics (NASDAQ:CERE) and Hallador Energy (NASDAQ:HNRG) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends, profitability and community ranking.
In the previous week, Hallador Energy had 1 more articles in the media than Cerevel Therapeutics. MarketBeat recorded 9 mentions for Hallador Energy and 8 mentions for Cerevel Therapeutics. Cerevel Therapeutics' average media sentiment score of 1.33 beat Hallador Energy's score of 0.51 indicating that Hallador Energy is being referred to more favorably in the news media.
Hallador Energy has higher revenue and earnings than Cerevel Therapeutics.
Hallador Energy received 87 more outperform votes than Cerevel Therapeutics when rated by MarketBeat users. However, 66.52% of users gave Cerevel Therapeutics an outperform vote while only 60.50% of users gave Hallador Energy an outperform vote.
87.7% of Cerevel Therapeutics shares are owned by institutional investors. Comparatively, 61.4% of Hallador Energy shares are owned by institutional investors. 5.1% of Cerevel Therapeutics shares are owned by insiders. Comparatively, 32.3% of Hallador Energy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Cerevel Therapeutics has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Comparatively, Hallador Energy has a beta of 0.45, meaning that its stock price is 55% less volatile than the S&P 500.
Cerevel Therapeutics currently has a consensus target price of $42.67, indicating a potential upside of 4.73%. Hallador Energy has a consensus target price of $9.00, indicating a potential upside of 0.33%. Given Hallador Energy's higher probable upside, analysts clearly believe Cerevel Therapeutics is more favorable than Hallador Energy.
Hallador Energy has a net margin of 3.79% compared to Hallador Energy's net margin of 0.00%. Cerevel Therapeutics' return on equity of 8.49% beat Hallador Energy's return on equity.
Summary
Hallador Energy beats Cerevel Therapeutics on 10 of the 14 factors compared between the two stocks.
Get Hallador Energy News Delivered to You Automatically
Sign up to receive the latest news and ratings for HNRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HNRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hallador Energy Competitors List
Related Companies and Tools
